James M. Gold, PhD
- 2Articles
- 6KReads1
- 2009–2011Active
- 13Collaborators
- 76Citations2
About
James M. Gold, PhD, has published research focusing on schizophrenia and schizoaffective disorders. His work includes clinical trials investigating pharmacological treatments such as bupropion sustained release for smoking cessation and atomoxetine for cognitive impairments in individuals with schizophrenia. He has collaborated frequently with co-authors including M. Patricia Ball, Robert P. McMahon, Robert W. Buchanan, A. Eden Evins, and Alison S. Buchholz. His articles appeared in Psychiatrist.com between 2009 and 2011.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
